Daily Sepsis Research Analysis
Three studies stand out today: a meta-analysis finds that 7-day antibiotic courses for adult bloodstream infections perform as well as 14-day regimens; a multi-hospital analysis shows each hour of delayed blood culture loading slightly reduces recovery, notably for streptococci; and a large cohort with Mendelian randomization suggests the sepsis "obesity paradox" is better explained by cardiometabolic medications than by adiposity itself.
Summary
Three studies stand out today: a meta-analysis finds that 7-day antibiotic courses for adult bloodstream infections perform as well as 14-day regimens; a multi-hospital analysis shows each hour of delayed blood culture loading slightly reduces recovery, notably for streptococci; and a large cohort with Mendelian randomization suggests the sepsis "obesity paradox" is better explained by cardiometabolic medications than by adiposity itself.
Research Themes
- Antimicrobial stewardship and optimal therapy duration in bloodstream infections
- Pre-analytical optimization of blood culture diagnostics
- Host factors versus pharmacotherapy in sepsis outcomes
Selected Articles
1. Clinical outcomes and safety of 7-day versus 14-day antibiotic therapy for bloodstream infections in adults: A systematic review and meta-analysis with trial sequential analysis.
Across four RCTs (n=4,794), 7-day antibiotic courses for adult bloodstream infections produced similar 90-day mortality and relapse rates as 14 days, with no excess adverse events. Trial sequential analysis flagged insufficient information size, but results support shorter courses in non-high-risk patients.
Impact: Directly informs antibiotic duration for bloodstream infections, a core decision in sepsis care, with rigorous synthesis of randomized evidence. Supports antimicrobial stewardship without compromising outcomes.
Clinical Implications: For non-high-risk adult BSIs, a 7-day course can be considered to reduce exposure, toxicity, and resistance pressure, while maintaining outcomes. Clinicians should individualize beyond 7 days for endovascular foci, immunocompromise, or slow clinical response.
Key Findings
- 7-day therapy had similar 90-day all-cause mortality to 14 days (RR 0.94, 95% CI 0.79–1.12; p=0.51).
- Bacteremia relapse did not differ between 7 and 14 days (RR 1.15, 95% CI 0.80–1.64; p=0.45).
- Adverse events (AKI, diarrhea, allergic reactions, C. difficile) were comparable between durations.
- Trial sequential analysis indicated the accrued information size remains insufficient.
Methodological Strengths
- Meta-analysis restricted to randomized controlled trials with comprehensive database search (PubMed, Embase, Cochrane).
- Use of trial sequential analysis to assess information size and control random errors.
Limitations
- Insufficient information size by TSA; potential underpowering for rare outcomes or high-risk subgroups.
- Generalisability limited to non-high-risk BSIs; heterogeneity in pathogen profiles and source control not fully explored.
Future Directions: Large, pragmatic RCTs stratified by infection source, pathogen, and host risk are needed to validate 7-day therapy across high-risk subgroups and to incorporate early response biomarkers.
The optimal duration of antibiotic therapy for bloodstream infections (BSIs) remains uncertain. This meta-analysis with trial sequential analysis (TSA) compared the efficacy and safety of 7-day versus 14-day antibiotic courses in adults. A systematic search of PubMed, Embase, and Cochrane Library identified four randomized controlled trials (4794 patients). The 7-day course showed similar 90-day all-cause mortality (RR 0.94, 95 % CI 0.79-1.12, p = 0.51) and bacteremia relapse rates (RR 1.15, 95 % CI 0.80-1.64, p = 0.45) compared to 14 days. No significant differences were found in adverse events, including acute kidney injury, diarrhea, allergic reactions, and Clostridioides difficile infections. TSA indicated an insufficient information size. While 90-day mortality is an objective endpoint, it may not fully capture clinical recovery or long-term sequelae. Nonetheless, the findings indicate that a 7-day antibiotic course achieves outcomes comparable to a 14-day regimen in non-high-risk patients, supporting shorter durations consistent with antimicrobial stewardship.
2. Rethinking the obesity paradox in sepsis: Metabolic pharmacotherapy explains survival benefits of obesity.
Using MIMIC-IV data (n=16,288) with multivariable modeling and Mendelian randomization, the protective association of overweight with 28-day sepsis mortality disappeared after adjusting for metabolic abnormalities, and no causal effect was found. Benefits were largely attributable to cardiometabolic medications.
Impact: Challenges a widely cited paradigm by disentangling adiposity from medication effects, reframing risk stratification and therapeutic considerations in sepsis.
Clinical Implications: Focus should shift from BMI-centric prognostication to evaluating and potentially optimizing chronic cardiometabolic pharmacotherapies around sepsis episodes, with prospective trials to test continuation or initiation strategies.
Key Findings
- After adjustment for metabolic abnormalities, overweight status showed no protective effect on 28-day mortality (adjusted HR 0.983; p=0.708).
- Mendelian randomization found no causal relationship between overweight, diabetes, hypertension, hyperlipidemia and 28-day sepsis mortality.
- Observed survival benefits were largely explained by medications (e.g., biguanides, sulfonylureas, β-blockers, ACE inhibitors, ARBs, diuretics, statins).
Methodological Strengths
- Large ICU cohort (MIMIC-IV) with multivariable Cox modeling and sensitivity analyses.
- Use of Mendelian randomization to interrogate causality beyond confounding.
Limitations
- Observational design with potential residual confounding and medication exposure misclassification.
- Single-database cohort may limit external generalizability; medication timing relative to sepsis onset not randomized.
Future Directions: Prospective interventional studies should test continuation/initiation of cardiometabolic agents during sepsis and evaluate pharmacologic phenotyping in risk models.
BACKGROUND & AIMS: Sepsis remains a leading global health burden. While the "obesity paradox" suggests improved outcomes in overweight and obese individuals, the impact of metabolic abnormalities (diabetes, hypertension, hyperlipidemia) and their associated pharmacotherapies on sepsis prognosis remains unclear. This study aimed to investigate the independent and synergistic effects of overweight status and metabolic abnormalities on sepsis mortality. METHODS: This retrospective cohort study utilized data from 16,288 sepsis patients in the Medical Information Mart for Intensive Care-IV database (version 3.1). We performed multivariable Cox regression to assess associations between overweight status (Body mass index ≥25 kg/m RESULTS: Overweight status lost its protective association with 28-day mortality after adjusting for metabolic abnormalities (adjusted hazard ratio 0.983, 95 % confidence interval 0.901-1.074, p = 0.708). MR analysis confirmed no causal relationship of overweight status, diabetes, hypertension and hyperlipidemia on sepsis-related 28-day mortality. The observed protective effects of metabolic abnormalities were explained by medications used to treat these conditions, including biguanides, sulfonylureas, β-blockers, Angiotensin-Converting Enzyme inhibitors, angiotensin II receptor blockers, diuretics, and statins. CONCLUSIONS: This study challenges the "obesity paradox" in sepsis, demonstrating that the observed protective effects of metabolic abnormalities are predominantly driven by pharmacological interventions. These findings underscore the importance of optimizing pharmacological strategies to enhance sepsis management.
3. Less haste, more speed: Does delayed blood culture transport time lead to adverse incubation times or yield?
In 398,077 analyzable blood culture sets from four hospitals, each hour of delayed loading led to a small reduction in yield (OR≈0.997 per hour), most pronounced for streptococci, with no loss for Gram-negatives, anaerobes, or yeasts. Delays paradoxically shortened time on incubators by ~10 minutes per delayed hour due to later start times.
Impact: Provides high-powered, methodologically rigorous evidence to optimize pre-analytical timelines for blood cultures, a cornerstone in sepsis diagnostics.
Clinical Implications: Prioritize prompt blood culture loading—ideally within 4 hours—especially when streptococcal infection is suspected, to marginally improve yield without affecting Gram-negatives or fungi.
Key Findings
- Per-hour delay in loading was associated with a small decrease in culture yield (OR 0.997; 95% CrI 0.994–1.001).
- Effect was greatest for Streptococcus species (pneumoniae, agalactiae, pyogenes).
- No evidence of reduced recovery for Gram-negatives, anaerobes, or yeasts with increasing TTL.
- Each hour of delay corresponded to ~10 minutes less time on incubators; no strong non-linearity observed.
Methodological Strengths
- Very large multicenter dataset with mixed-effects Bayesian modeling and GAM to assess non-linearity.
- Granular time-stamped pre-analytical variables (TTL, sent time) and organism-level analyses.
Limitations
- Retrospective observational design with potential residual confounding (e.g., sampling time, patient severity).
- Effect size is small; operational changes may yield modest absolute benefits.
Future Directions: Prospective implementation studies should test process interventions (e.g., on-ward incubators, courier logistics) and measure clinical endpoints in suspected sepsis.
BACKGROUND: Blood culture remains a vital diagnostic tool in the acutely unwell patient. The UK Standards for Microbiology Investigations (SMI) stipulate pre-analytical requirements that are aimed at increasing yield and reducing turnaround time. The requirement to load blood cultures on machines within 4 h has been shown to reduce turnaround time but limited evidence exists as to whether it improves yield. METHODS: We extracted blood culture results, including organism growth, time to detection, location and time of sample collection from 4 hospitals in Southwest England. We then used mixed effects, Bayesian linear and logistic regression models to examine the effect of predictor variables like time to laboratory (TTL) and sent time on the response variable of growth or time to detection. We fitted generalised additive models to explore non-linearity. RESULTS: 449,191 culture sets were analysed, 398,077 of which had enough data to include in the final analysis. 37,255 sets flagged positive (9.36%) of which 21,330 were considered pathogens. Our primary analysis identified a small decrease in yield with each hours delay in loading (0.997 (95%CrI 0.994-1.001)). This effect was largest in Streptococcus pneumoniae, agalactiae and pyogenes. In our analysis on time on the machine, culture sets spend 10.03 (95%CrI 12.66-7.31) minutes less on incubators for each hour delay. Neither anaerobes nor yeasts showed any loss of recovery from increasing TTL. There was no convincing non-linearity in either of these effects. CONCLUSION: There is a marginal loss of growth for every hour a blood culture is left unincubated, with the loss of recovery of Streptococcus pyogenes and other streptococci being most common. There was no evidence of a reduction in Gram-negatives, anaerobes, or yeasts. There was a small decrease in time to detection for delayed sets. This analysis suggests there may be marginal benefit in reducing time to load.